Concentration dependent degradation of pharmaceuticals in WWTP effluent by biofilm reactors.
Michaelis-Menten kinetics
Moving Bed Biofilm reactor
Organic micropollutants
Pharmaceuticals
Wastewater treatment plant effluent
Journal
Water research
ISSN: 1879-2448
Titre abrégé: Water Res
Pays: England
ID NLM: 0105072
Informations de publication
Date de publication:
01 Nov 2020
01 Nov 2020
Historique:
received:
08
06
2020
revised:
28
08
2020
accepted:
03
09
2020
pubmed:
12
9
2020
medline:
18
11
2020
entrez:
11
9
2020
Statut:
ppublish
Résumé
Conventional wastewater treatment lacks the ability to remove many pharmaceuticals. This is leading to emissions to the natural aquatic environment, where these compounds pose a risk to the aquatic organisms. An advanced wastewater treatment technique that has shown promising results is Moving Bed Biofilm Reactors (MBBR). Initial degradation velocity and degradation rate constants of the pharmaceuticals are important parameters for designing an optimal MBBR system; however, the degradation efficiency varies across studies and one of the most plausible causes might be initial concentration. Thus, to verify the effect of initial concentration, the degradation of a mixture of 18 pharmaceuticals at different initial concentrations was studied. For this study MBBR's with very low BOD loading were used as they were conditioned with effluent water. The experiment was set up as a MBBR batch incubation, using effluent wastewater as medium, spiked with the 18 pharmaceuticals in seven different concentration levels (approximately 0-300 µg L
Identifiants
pubmed: 32916616
pii: S0043-1354(20)30924-6
doi: 10.1016/j.watres.2020.116389
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Waste Water
0
Water Pollutants, Chemical
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
116389Informations de copyright
Copyright © 2020. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.